Wednesday, August 22, 2012

Harvesting Potatoes

Harvesting Potatoes
and cooking potatoes too.


This week's video reflects back to the day we planted the potatoes (notice my son is planting them), we show the harvesting of the potatoes, demonstrate a recipe using our potatoes and enter some potatoes at the fair. See how things turned out. 

Recipe:
Roasted Rosemary Potatoes

5 pounds potatoes
1/4 cup olive oil
5-6 springs rosemary
garlic powder or granulated garlic
Kosher salt
black pepper

Preheat oven to 425ยบ.
Pour oil into a 10"x 13" pan.
Wash potatoes and slice them into bite-sized pieces. Add them to the pan.
Pull the leaves off the rosemary stems and sprinkle them over the potatoes.
Sprinkle potatoes with kosher salt, pepper, and garlic.
Stir potatoes, making sure to coat all of them with oil.
Put the pan in the hot oven and cook for about 1 hour, or until potatoes are soft. Stir potatoes again before serving.

Potatoes are a high starch, cheap food. But, as far as I am concerned, they are essential on the homestead. A five pound bag of potatoes could cost as little as $1.69 (August 8-15, 2012; Albertson's Flyer; Price with Preferred Savings Card). The question is: Why would anyone in their right mind grow their own potatoes if you can buy 5 pounds for a buck-seventy? Heck, I may have only gotten 100-150 pounds of potatoes and will likely only eat 50 pounds during the season and from what I can preserve (some will suffer spoilage and some will be given away). That works out to about $85.00 for all that hard work in preparing the soil, planting, watering, weeding, harvesting and storage.

Rumors have it that potato farmers will not even eat their own potatoes (rumors; not validated (http://veggierevolution.blogspot.com/2010/10/experts-avoid-nonorganic-potatoes.html)). I wondered why. Here's a web site that may demonstrate some of the farming practices in growing and harvesting potatoes:

http://oregonstate.edu/potatoes/vine.htm 

I am not being critical only to the farmer; consumer responsibility comes into play here as well. Think about it: 5 pounds of potatoes for a dollar and sixty-nine cents. In the same ad where I discovered this deal on potatoes, Albertson's was offering 3-two liter bottles of soda for 4 bucks. Consumers are not willing to pay for good food. We want food that looks good and "seems" good and is CHEAP. After all, Endothall is an organic solid of white odorless crystals. If we don't know it's in there, then it can't hurt us, right? 

http://water.epa.gov/drink/contaminants/basicinformation/endothall.cfm
http://www.lclabs.com/MSDS/E-4505MSDS.php4

The problem for me is: In order to create a potato that is marketable to the general consumer, it must look a certain way, it must be a certain size, it can't have blemishes, it can't have protrusions and be grown together with other potatoes and the like. Farmers want to harvest potatoes on their schedule and beat the fall moisture that will cause all kinds of problems. So, they soak the potatoes in herbicides to kill off that which is above the ground.  

According to Dr. Holly Menninger, NY Invasive Species Research Institute (http://ccetompkins.org/environment/invasive-species/hydrilla-endothal-treatment-faq), "The use of any aquatic herbicide poses risks to non-target plants and aquatic organisms." She does throw a "but" in there, but (there's mine), that just does not sit well with me. I chose to grow my own. 

Links:



Hope you enjoyed the video.

3 comments:

  1. Guangzhou Academy of biological treatment of leukemia drug research for new breakthroughs

    Small molecule inhibitor of Bcr-Abl Imatinib has been a great success in the clinical treatment of chronic myeloid leukemia (CML) and other diseases. Bcr-Abl mutations induced drug resistance has become an important issue in today's medical oncology. Second-generation drug Nilotinib and Dasatinib only to overcome the resistance caused by mutations in some genes, and Bcr-AblT315I the highest incidence of drug-resistant mutations invalid. The ponatinib December 2012 to overcome the Bcr-AblT315I resistance has just been approved by the FDA listed, but the P-Loop area mutations on the Bcr-AblE255K / V, etc. ineffective.

    Recently, the Chinese Academy of Sciences Guangzhou Institute of Biomedicine and Health, Dr. Ding Ke led the team to successfully design and synthesis of aryl alkynes and triazole benzamide two types of small molecule inhibitors of Bcr-Abl after nearly four years of technical research. Compounds in a variety of kinases, cell and animal models can effectively overcome the problem of resistance the Bcr-AblT315I mutations induced. Which compounds GZD824 can pM IC50 values ​​suppression the Bcr - AblWT and Bcr-AblT315I of resistant mutants kinase activity (respectively 0.34 and 0.68 nm), and the P-loop mutations (E255K / V). Compound in a variety of cell and animal models exhibit excellent anti-tumor activity (IC50 against the CML K562, Ku812 tumor cells 0.2-10nm; for Family the Bcr-AblT315I mutants Ba/F3 cells IC50 approximately 7Nm; in completely inhibit tumor growth the 1.0-20.0mg/kg/day oral dose) the and better safety indicators and excellent pharmacokinetic properties (rat oral bioavailability of approximately 48.7%; vivo half-life T1 / 2 of approximately 8-10 hours). Currently GZD824 have been identified as candidate drugs, the specification of ongoing pre-clinical Evaluation.


    Medchemexpress Can provide the above product,its website:www.medchemexpress.com



    Tandutinib
    KW-2449
    Quizartinib
    AST 487
    Linifanib
    Canertinib
    Canertinib dihydrochloride
    CP-724714 (E-Double bond)
    2-Methoxyestradiol
    GSK1904529A

    ReplyDelete
  2. Vascular endothelial growth factor (VEGF) inhibitors

    Genentech and Roche to jointly develop Avastin is inhibition of VEGF humanized monoclonal antibody, its listing in December 2004, for the treatment of colorectal cancer. On the 41st Annual Meeting of the American Society of Clinical Oncology, published Avastin and Tarceva (erlotinib) combination therapy of renal cell carcinoma Phase II clinical trial report, the results show the efficacy of 25% of patients, 36% of patients were able to stabilize the disease .

    In December 2005, Roche began in the U.S. Phase III clinical trials of bevacizumab (bevacizumab) combined with interferon treatment of renal cell carcinoma. Sutent (sunitinib malate) is an oral vascular endothelial growth factor (VEGF) receptor, platelet-derived growth factor receptor, and KIT and FLT3 tyrosine kinase. Currently being developed by Pfizer for the treatment of a variety of tumors. In the United States and European Phase III clinical study.

    Medchemexpress Can provide the above product,its website:www.medchemexpress.com



    GSK1904529A
    Linsitinib
    NVP-ADW742
    BMS-536924
    GSK1904529A
    NVP-AEW541
    Linsitinib
    Pazopanib
    Crenolanib
    Toceranib

    ReplyDelete
  3. JBC: confirmed two kinds of anti-cancer drugs that inhibit influenza virus infection

    University of Helsinki, Finland, from the Finnish Institute for Molecular Medicine, a medical systems virology team collaboration with other partners to develop a new cell-based screening method, and this method can be used to identify influenza antiviral drugs. Researchers have identified two new anti-influenza virus activity of the compound obatoclax and gemcitabine (gemcitabine), a previously known and confirmed the efficacy of drugs saliphenylhalamide. This study has been published in the Journal of Biological Chemistry journals.

    Influenza virus to cause significant morbidity and mortality people. For the treatment of these viral infections, various targeting viral drugs have been developed. However, currently available drugs are targeting viral proteins, but because influenza viruses mutate rapidly develop resistance to them. For this reason, should be targeted next host antiviral function. The results of this study lay the foundation for developing the next generation of antiviral drugs. Furthermore, these drugs have been identified chemical tools can be used to enable the study of virus - host interactions molecular mechanism.

    Corresponding author Denis Kainov papers, says the study's interesting is that the drug obatoclax, saliphenylhalamide and gemcitabine even mediated cell death in higher than lower concentrations needed, they can exhibit anti-viral effect. However, these drugs can be used in clinical testing and influenza virus infection before, further research is needed.




    Medchemexpress Can provide the above product,its website:www.medchemexpress.com



    RAF265
    Sunitinib Malate
    Vandetanib
    PD173074
    Regorafenib
    Brivanib alaninate
    Brivanib
    SU 5402
    TSU-68
    Tivozanib

    ReplyDelete